OKYO

OKYO PHARMA LTD

OKYO·G6724L116·US·Common Stock·Healthcare - Biotechnology-13D/G

OKYO (OKYO PHARMA LTD) is held by 8 institutional investors as of Q1 2026. Largest holders: Woodline Partners LP ($5.9M), BALYASNY ASSET MANAGEMENT L.P. ($941,522), UBS Group AG ($96,214). Net institutional sentiment: Mixed.

8
Holders
Avg rating(3 Elite)
$7M
Total Value
67% (10)
Fund Consensus
4 buying - 2 selling
OKYOSmart Money Verdict
View all
Held by 8 funds
3 elite
Who's Trading
ActivistSISirenia Capital Management LP7.7%May 15, 2026
ActivistWoodline Partners LPWoodline Partners LP7.0%May 15, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.0.0%May 15, 2026
ActivistCJChernett Jorey9.5%Feb 13, 2026
ActivistDIDauntless Investment Group, LLC1.2%Feb 12, 2026
ActivistLNLAURA NATALIA MONICA FONDA5.0%Oct 29, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
3.7M$5.9M0.0%-0.59%
38
New
584,796$941,5220.0%-0.59%
35
Increased
59,760(+2651.4%)$96,2140.0%-1.09%
24
Increased
37,652(+113.8%)$60,6200.0%-6.75%
34
Unchanged
12,812$20,6270.0%-3.37%
0
Unchanged
12,090$19,4640.0%-8.65%
0
Unchanged
152$2440.0%-15.50%
0
Unchanged
10$160.0%-12.89%
0
Exited
0(-100.0%)$21,2000.0%-30.61%
0
Exited
0(-100.0%)$285,6600.0%-13.17%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used